Helicos BioSciences Corporation
(NASDAQ:HLCS)|
1.49 +0.35 (30.70%) Jan 07 - Close |
|
|
|
After-Hours 1.34 -0.15 (-10.07%) Wed, 7 Jan 2009 7:40 PM
- Compare HLCS with:
- View: Line | Candlestick
Company Profile
Helicos BioSciences Corporation
One Kendall Square
Cambridge, MA 02139
United States - Map
Phone: (617) 264-1800
Fax: (617) 264-1700
Website: www.helicosbio.com
CEO: Ronald A. Lowy
Employees: 114
Sector: Healthcare
Industry Group: Drugs
Industry: Drugs - Generic
Engaged in research/drug disc/clinical diagnstc mk
A life sciences company, which focuses on innovative genetic analysis technologies for the research, drug discovery and clinical diagnostics markets.
Recent news for HLCS
-
HELICOS BIOSCIENCES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Dec 30 2008 at 8:43 ET
-
EDGAR Online - Dec 22 2008 at 4:47 ET
-
Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement
Business Wire - Dec 19 2008 at 9:16 ET
-
HELICOS BIOSCIENCES CORP Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online - Dec 19 2008 at 8:56 ET
-
EDGAR Online - Dec 17 2008 at 10:41 ET
-
HELICOS BIOSCIENCES CORP Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online - Dec 16 2008 at 6:01 ET
-
HELICOS BIOSCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Dec 08 2008 at 4:40 ET
-
EDGAR Online - Dec 04 2008 at 4:54 ET
-
EDGAR Online - Dec 02 2008 at 5:16 ET
-
Helicos BioSciences Corporation Realigns Senior Management Team
Business Wire - Dec 02 2008 at 10:02 ET